New Delhi, March 23 A study has identified a new biomarker for schizophrenia, which could also serve as a target for drugs to treat cognitive symptoms such as disorganized thinking or executive function.Schizophrenia is a mental health disorder characterized by an impaired ability to perceive...
biomarker
brain circuits
brain plasticity
cacna2d1
cerebrospinal fluid
clinical trials
cognitive symptoms
drug development
mentalhealthdisorders
neuroscience
peptide therapy
protein
research study
schizophrenia
synapses
New Delhi, March 9 One in seven Indians is affected by mental health disorders, while several states continue to face a treatment gap ranging from 70 to 90 per cent, experts said on Monday.In a post-budget webinar breakout session, experts discussed the Union Budget announcements, which focus...
abha id
ayushman bharat digital mission
digital healthhealthcare infrastructure
india
mentalhealthmentalhealthdisorders
national health mission
neurological disorders
neuropsychiatric care
nimhans
non-communicable diseases
north india
specialised services
telemedicine
tertiary healthcare
New Delhi, February 17 Deep-tech firm NeuroDx announced on Tuesday that it has developed a 400-million-parameter AI brain language model, Manas-1, to decode the electrical activity of the human brain.The model aims to bring major changes to diagnostics, especially in neuroscience, by enabling...
ai asset
ai development
artificial intelligence
biosignals
brain language model
deep learning
diagnostics
epilepsy
healthcare
india
manas-1
mentalhealthdisorders
neurodx
neurology
neuroscience